Integration of monitoring technology for heart failure

Current Opinion in Cardiology

Volumn 27, Issue 2, 2012, Pages 130-136

  Clarke, Brian ^a,b   Howlett, Jonathan ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

heart failure; implantable hemodynamic monitors; intrathoracic impedance; multidisciplinary disease management; outcomes

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DEFIBRILLATOR; FOLLOW UP; HEART FAILURE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; MONITOR; PATIENT EDUCATION; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; REVIEW; TELEMONITORING; THORAX PRESSURE;

CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HEMODYNAMICS; HUMANS; MONITORING, PHYSIOLOGIC; REPRODUCIBILITY OF RESULTS;

EID: 84856932332     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283502137     Document Type: Review

References (40)

1. Ahmed A, Allman RM, Fonarow GC, et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: A propensity-matched study. J Card Fail 2008; 14:211-218. (Pubitemid 351434595)
2. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29:2388-2442.
3. Pang PS, Komajda M, Gheorghiade M. The current and future management of acute heart failure syndromes. Eur Heart J 2010; 31:784-793.
4. ADHERE - Acute Decompensated Heart Failure National Registry. Q1 2004 national benchmark report. Atlanta, GA: Adair-Greene Healthcare Communications; 2004. pp. 1-21.
5. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007; 297:61-70. (Pubitemid 46041727)
6. Howlett JG, Johnstone DE, Sketris I, et al. Identifying opportunities to address the congestive heart failure burden: The Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol 2003; 19:439-444. (Pubitemid 36603514)
7. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary update 2005: The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:1115-1140.
8. Heart Failure Society of America. Executive summary: HFSA 2006. Comprehensive heart failure practice guidelines. J Card Fail 2006; 12:10-38.
9. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006; 22:23-45.
10. Rumsfeld JS, Masoudi FA. Heart failure disease management works, but will it succeed? Eur Heart J 2004; 25:1565-1567. (Pubitemid 39209276)
11. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989; 261:884-888. (Pubitemid 19046417)
12. Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures. Circulation 2004; 109:2432-2439.
13. Lewin J, Kedwidge M, O'Laughlin C, et al. Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail 2005; 7:953-957. (Pubitemid 41443587)
14. Jaarsma T, van der Wal M, Lesman-Leegte I, et al. Effect of moderate or intensive disease management programs on outcome in patients with heart failure. Arch Intern Med 2008; 168:316-324.
15. McAlister F, Stewart S, Ferrua S, McMurray J. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. A systematic review of randomized trials. J Am Coll Cardiol 2004; 44:810-819. (Pubitemid 39099578)
16. Gonseth J, Guallar-Castillon P, Banegas J, Rodriguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: A systematic review and meta-analysis of published reports. Eur Heart J 2004; 25:1570-1595. (Pubitemid 39209278)
17. Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363:2301-2309.
18. Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. CochraneDatabase Syst Rev 2011; 6:CD007228
19. Stevenson LW, Zile M, Benett TD, et al. Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 2010; 3:580-587.
20. Wang L, Lahtinen S, Lentz I, et al. Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing Clin Electrophysiol 2005; 28:404-411. (Pubitemid 40696301)
21. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112:841-848. (Pubitemid 41170070)
22. Vollman D, Nagele H, Schauerte P, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007; 28:1835-1840. (Pubitemid 47236638)
23. Maines M, Catanzariti D, Cemin C, et al. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study. J Interv Card Electrophysiol 2007; 19:201-207. (Pubitemid 47573216)
24. Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs. daily weight monitoring for predicting worsening heart failure events: Results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 2011; 17:51-55.
25. Small R, Wickemeyer W, Germany R, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: Clinical utility of implanted device monitoring with a patient alert. J Card Fail 2009; 15:475-481.
26. Pergo GB, Landolina M, Vergara G, et al., OptiVol-CRT Clinical Service Observational Group. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. J Interv Card Electrophysiol 2008; 23:235-242.
27. Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: The SENSE-HF trial. Eur Heart J 2011; 32:2266-2273.
28. Sarkar S, Hettrick DA, Koehler J, et al. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices. J Card Fail 2011; 17:569-576.
29. Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS-HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) Study. J Am Coll Cardiol 2010; 55:1803-1810.
30. Auricchio A, Brugada J, Ellenbogen K, et al. Assessment of a novel devicebased diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: Rationale and design of the CLEPSYDRA study. Eur J Heart Fail 2010; 12:1363-1371.
31. Tallaj J, Singla I, Bourge R. Implantable hemodynamic monitors. Cardiol Clin 2011; 29:289-299.
32. Magalaski A, Adamson P, Gadler F, et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter 12-month follow-up study of patients with chronic heart failure. J Card Fail 2002; 8:63-70. (Pubitemid 34521414)
33. Adamson PB, Magalski A, Braunschweig F, et al. Ongoing right ventricular hemodynamics in heart failure- clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 2003; 41:565-571. (Pubitemid 36223320)
34. Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure; the COMPASS-HF study. J Am Coll Cardiol 2008; 51:1073-1079. (Pubitemid 351374766)
35. Adamson PB, Conti JB, Smith Al, et al. Reducing events in patients with chronic heart failure (REDUCEhf) study design: Continuous hemodynamic monitoring with an implantable defibrillator. Clin Cardiol 2007; 30:567-575. (Pubitemid 350209968)
36. Ritzema J, Troughton R, Melton I, et al. Physician-directed patient selfmanagement of left atrial pressure in advanced chronic heart failure. Circulation 2010; 121:1086-1095.
37. Verdejo HE, Castro PF, Concepcion R, et al. Comparison of a radiofrequencybased wireless pressure sensor to Swan-Ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. J Am Coll Cardiol 2007; 50:2375-2382. (Pubitemid 50011581)
38. Hoppe UC, Vanderheyden M, Sievert H, et al. Chronic monitoring of pulmonary artery pressure in patients with severe heart failure: Multicentre experience of the monitoring Pulmonary Artery Pressure by Implantable device Responding to Ultrasonic Signal (PAPIRUS) II study. Heart 2009; 95:1091-1097.
39. Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure; a randomized controlled trial. Lancet 2011; 377:658-666.
40. Vanderheyden M, Houben R, Verstreken S, et al. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure. Circ Heart Fail 2010; 3:370-377.